07.12.2012 Views

A Review of immunomodulators with reference to Canova - Similima

A Review of immunomodulators with reference to Canova - Similima

A Review of immunomodulators with reference to Canova - Similima

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Review</strong> <strong>of</strong><br />

<strong>immunomodula<strong>to</strong>rs</strong> <strong>with</strong><br />

<strong>reference</strong> <strong>to</strong> <strong>Canova</strong><br />

E.Smit, H.Moberholzer & E.Pre<strong>to</strong>rius<br />

Dept <strong>of</strong> Ana<strong>to</strong>my, University <strong>of</strong> Pre<strong>to</strong>ria,<br />

S. Africa<br />

www.similima.com 1


Immunomodla<strong>to</strong>r – Substances which modify the immunity<br />

<strong>of</strong> an individual <strong>to</strong> favour a particular immunological response<br />

<strong>Canova</strong> – A Homoeopathic product produced according <strong>to</strong><br />

Hahnemanian homoeopathic method in Brazil<br />

Its role in Carcinoma, Haema<strong>to</strong>poesis, Macrophage &<br />

Monocyte activation, its ability <strong>to</strong> stabilize platelet morphology<br />

in AIDS is reviewed<br />

www.similima.com 2


Introduction<br />

Immunity is the reaction <strong>of</strong> cells & tissues <strong>to</strong> foreign<br />

substances / Pathogens<br />

Immune response requires timely interplay <strong>of</strong> multiple cell<br />

types <strong>with</strong> in specific microbiological environment <strong>to</strong><br />

maintain immune homeostasis<br />

Innate – First encounter <strong>to</strong> a pathogen ( Inborn)<br />

Contributed by Neutrophil, Monocyte & Macrophage<br />

Adaptive / Acquired – Consequences <strong>of</strong> an initial exposure<br />

( Developed). Contributed by B & T Lymphocytes &<br />

Cy<strong>to</strong>kines<br />

www.similima.com 3


Immunomodula<strong>to</strong>rs – Agents <strong>to</strong> enhance a particular<br />

immunological response available as TLR ( Toll like recep<strong>to</strong>rs),<br />

Cy<strong>to</strong>kines, Cy<strong>to</strong>kine recep<strong>to</strong>rs, Transcription fac<strong>to</strong>r modulation,<br />

Cell surface molecule, T H subset balance, Signalling sequence<br />

& gene activation<br />

1) Specific <strong>to</strong> pathogen – Includes Ab reagents & Vaccines<br />

2) Non specific – Includes Cy<strong>to</strong>kine, Antimicrobial peptide,<br />

Antimicrobial drugs & microbe (Probiotics)<br />

www.similima.com 4


Immune response<br />

Ag presenting cells ( Dendritic cells, Monocytes, Macrophage)<br />

at the site <strong>of</strong> entry <strong>of</strong> microbes ( Skin, GIT, Respi) capture Ag <strong>of</strong><br />

microbe by phagocy<strong>to</strong>sis / pinocy<strong>to</strong>sis<br />

Move <strong>to</strong> T cell rich lymph node <strong>with</strong> the help <strong>of</strong> cy<strong>to</strong>kines<br />

(IL,TNF) produced by sorrounding cells<br />

During migration they mature & start <strong>to</strong> express MHC (Major<br />

his<strong>to</strong>compatibilty complex) which display Ag <strong>to</strong> the cells<br />

www.similima.com 5


� T Lymphocytes (Helper) stimulate B Lymphocytes <strong>to</strong><br />

produce Ab which are recognized by phagocytes<br />

Endocy<strong>to</strong>sis / pinocy<strong>to</strong>sis<br />

Fuses <strong>to</strong> lysosome<br />

Ag are digested by proteolytic enzymes <strong>to</strong> peptides<br />

� Ag recognized by CD8 & T cells Cy<strong>to</strong><strong>to</strong>xic T cells<br />

which kill infected cells <strong>with</strong> foreign Ag<br />

� T cells secrete cy<strong>to</strong>kines when recognizes the co stimula<strong>to</strong>rs<br />

on APC (Ag presenting cells) Proliferation &<br />

differentiation <strong>of</strong> T cells<br />

www.similima.com 6


Human MHC proteins – HLA decided by gene on Chr 6<br />

(A ,B,C – class I DP, PQ, DR – ClassII)<br />

Each bind preferentially <strong>to</strong> different Antigenic peptides<br />

Responsible for Variation in immune responsiveness <strong>to</strong><br />

particular Ag in different individual<br />

www.similima.com 7


TLR ‘s are recognition recep<strong>to</strong>rs that are activated by<br />

specific components, microbes & certain host molecules<br />

13 mamallian TLR’s which can be activated by pathogens<br />

(Exogenous) & immune related (endogenous) are<br />

identified<br />

An Ag when taken up by an APC, the TLR ‘s are stimulated<br />

Increase MHC Ag & cy<strong>to</strong>kine production<br />

Stimulate other APC’s & T & B Lymphocytes<br />

Proper immune response<br />

www.similima.com 8


Immunomodula<strong>to</strong>ry therapies involve one / multiple TLR’s<br />

� Lipid A component <strong>of</strong> lipopolysacharride is a TLR agonist<br />

that induce Th 1 response<br />

� By blocking / stimulating TLR’s, a modification Th1 / Th2<br />

cy<strong>to</strong>kine balance can effect various immunological status<br />

TLR 9 – Allergic disease<br />

CpG – Infectious disease like Hepatitis B, C, Anthrax ,<br />

influenza, Ca, Melanoma<br />

(In combination <strong>with</strong> chemotherapy / adjuvant)<br />

www.similima.com 9


Cy<strong>to</strong>kines are diverse family <strong>of</strong> polypeptide hormone & growth<br />

fac<strong>to</strong>r that regulate many cellular processes produced by<br />

variety <strong>of</strong> immune cells <strong>to</strong> communicate & orchestrate an<br />

immune attack<br />

Modulation <strong>of</strong> cy<strong>to</strong>kine secretion may <strong>of</strong>fer novel approaches<br />

in treatment <strong>of</strong> various diseases<br />

Done by implementation <strong>of</strong> antiinflamma<strong>to</strong>ry cy<strong>to</strong>kines<br />

(IF,IL 4,GF) / neutralizing proinflamma<strong>to</strong>ry cy<strong>to</strong>kines ( IL 2, IF<br />

gamma, TNF)<br />

IL - Used in treatment <strong>of</strong> RA ( Prevents interaction <strong>of</strong> IL1 <strong>to</strong> its<br />

cell surface recep<strong>to</strong>rs)<br />

TNF – RA, Crohn’s disease, Psoriasis ( AI )<br />

INF alpha – advanced melanoma<br />

www.similima.com 10


One <strong>of</strong> the key concept <strong>of</strong> homoeopathy is stimulation <strong>of</strong><br />

body’s defense mechanisms in the process <strong>to</strong> prevent / treat<br />

illness<br />

In the process <strong>of</strong> succussion there is an antigenic imprinting <strong>of</strong><br />

the crystalline lattice <strong>of</strong> water even though no single molecule /<br />

molecular remnant <strong>of</strong> <strong>of</strong> original substance is present<br />

www.similima.com 11


CANOVA is a homoeopathic product developed & produced<br />

according <strong>to</strong> Hahnemanian method as a homoeopathic<br />

remedy in Brazil<br />

Contains –Thuja, Bryonia, Aconite, Arsenic Alb & Lachesis<br />

No <strong>to</strong>xicity / mutagenic effects have been reported<br />

Available as drops in concentration ranging from 4% <strong>to</strong> 50%<br />

50ml contains 49.965ml water & 0.035ml alcohol<br />

Researchers have found that it stimulates host defense in<br />

pathological states<br />

www.similima.com 12


Invitro study <strong>of</strong> canova on BM cells showed activation<br />

Invivo & invitro study <strong>with</strong> canova showed activation <strong>of</strong><br />

macrophages, enhanced spreading <strong>of</strong> cells & formation <strong>of</strong><br />

microvillous extrusions<br />

Activation <strong>of</strong> Monocytes, differentiation <strong>to</strong> macrophages <strong>with</strong><br />

increased expression <strong>of</strong> CD8<br />

Like cy<strong>to</strong>kine, <strong>Canova</strong> induces differentiation <strong>of</strong> monocytes<br />

immunomodula<strong>to</strong>ry activity<br />

www.similima.com 13


In sarcoma - <strong>Canova</strong> treated mice showed delay in<br />

development & reduction in size <strong>of</strong> the tumor, increased<br />

infiltration <strong>of</strong> lymphoid cells, GT & fibrosis sorrounding the<br />

tumor, Leucocy<strong>to</strong>sis & Lymphocy<strong>to</strong>sis ( enhanced immune<br />

response) compared <strong>to</strong> control group<br />

Macrophages showed 86% activation in <strong>Canova</strong> treated & 15%<br />

activation in control<br />

TNF alpha production was decreased while IL2 & IFN gamma<br />

revealed no difference <strong>with</strong> control group<br />

www.similima.com 14


Leishmania – Reduced infection & decreased parasite load in<br />

regional LN & spleen (in vivo)<br />

<strong>Canova</strong> caused indirect proliferation <strong>of</strong> lymphocytes<br />

(Thro’activated macrophages)<br />

Increases Leucocytes, number <strong>of</strong> CD4 T lymphocytes, NK<br />

cells in peripheral blood<br />

Increase in no. <strong>of</strong> adherent, larger & activated cells in canova<br />

treated group.<br />

HIV – Less morphological changes in platelet, less pronounced<br />

membrane blebbing ( prevents thrombocy<strong>to</strong>penia)<br />

Protects membranes <strong>of</strong> platelets & thereby immune system by<br />

protecting ultrastructure<br />

www.similima.com 15


Conclusion<br />

<strong>Canova</strong> is a complex homoeopathic remedy used as<br />

immunomodula<strong>to</strong>r<br />

It activates macrophages, stimulates differentiation &<br />

modulates other inflamma<strong>to</strong>ry process<br />

More research is needed <strong>to</strong> expand the possible uses &<br />

application <strong>of</strong> homoeopathic immunomodula<strong>to</strong>r<br />

www.similima.com 16


Immunomodula<strong>to</strong>rs<br />

Homoeopathic medicines act by immunomodulating ?.......<br />

Homoeopathic medicine given in other countries<br />

Only succussions - Homoeopathic preparation<br />

Different dilutions – 4%, 50% etc<br />

Mixing – Should we try?<br />

www.similima.com 17


www.similima.com 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!